Literature DB >> 33681939

Campylobacter fetus spondylodiscitis during immunochemotherapy for non-Hodgkin's lymphoma.

Jéssica Santos Cunha1, Fernando Franco Lafetá Queiroz1, Rodrigo Juliano Molina2, Leonardo Rodrigues de Oliveira3.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33681939      PMCID: PMC8008919          DOI: 10.1590/0037-8682-0801-2020

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


× No keyword cloud information.
A 58-year-old man presented with fever and backache, which he had begun experiencing 3 h before admission. Laboratory tests showed normal leukocyte (4.2×109/L) and neutrophil (4.1×109/L) counts, lymphocytopenia (85/mm³), and increased C-reactive protein level (23.1 mg/dL, normal up to 0.5 mg/dL). The patient was administered rituximabe for mantle cell non-Hodgkin's lymphoma following eight immunochemotherapy sessions. Contrast-enhanced computed tomography was undertaken for persistent backache, which revealed a lytic lesion in the T12 region. Nuclear magnetic resonance demonstrated changes that were aligned to spondylodiscitis (Figure 1). There was no evidence of lymphoma relapse. Campylobacter fetus (C. fetus) infection was confirmed using a mass spectrometer. Treatment was initiated with the administration of intravenous azithromycin (500 mg/day) and gentamicin (240 mg/day) for 14 days, followed by intravenous ertapenem (1 g/day) for an additional 14 days in an outpatient setting. Fever and back pain were managed in a constant and sustained manner.
FIGURE 1:

Magnetic resonance imaging with gadolinium infusion of the lumbar spine in T1 sequence (A), T2 sequence (B) and short TI inversion recovery (STIR) mode (C). The findings include diffuse disc edema and inflammation between T10 and T11 and T12 and L1 vertebral bodies (arrows), with no abscess or significant reduction in the height of the vertebral bodies.

Spondylodiscitis is the inflammation of the intervertebral discs and adjacent vertebral bodies. Campylobacter bacteria are rarely reported to be the cause of spondylodiscitis . Spondylodiscitis is an uncommon infection and is related to risk factors such as diabetes mellitus, malnutrition, immunosuppression, neoplasms, renal failure, HIV infection, alcoholism, and gastrointestinal surgery . Spondylodiscitis occurs predominantly by hematogenous dissemination of pathogens into the urinary tract, respiratory tract, or soft tissues . Spondylodiscitis due to C. fetus is very rare; hence, its management and optimal treatment has not been identified .
  3 in total

Review 1.  [Campylobacter fetus spondylodiscitis].

Authors:  C Bachmeyer; G Grateau; D Sereni; G A Cremer
Journal:  Rev Rhum Mal Osteoartic       Date:  1992-01

Review 2.  Pyogenic Spondylitis: Clinical Features, Diagnosis and Treatment.

Authors:  Kimiaki Sato; Kei Yamada; Kimiaki Yokosuka; Tatsuhiro Yoshida; Masafumi Goto; Tsunemasa Matsubara; Shoji Iwahashi; Takahiro Shimazaki; Kensei Nagata; Naoto Shiba
Journal:  Kurume Med J       Date:  2019-08-09

3.  Campylobacter spondylodiscitis and deficiency of cellular immunity.

Authors:  E Mathieu; A C Koeger; S Rozenberg; P Bourgeois
Journal:  J Rheumatol       Date:  1991-12       Impact factor: 4.666

  3 in total
  1 in total

1.  Case Report: Campylobacter fetus caused pyogenic spondylodiscitis with a presentation of cauda equina syndrome after instrumented lumbar fusion surgery.

Authors:  Matevž Topolovec; Nataša Faganeli; Peter Brumat
Journal:  Front Surg       Date:  2022-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.